ArticleScientific reports2017

In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment.

Onkar Nath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.